Skip to main navigation
Skip to search
Skip to main content
Sort by
Keyphrases
Microbiomics
100%
Metformin Treatment
100%
Metabolomics
100%
Metformin
100%
Pharmacogenomics
100%
Qatari
100%
Type 2 Diabetic Patients
100%
Metabolic Signature
33%
Alpha Diversity
16%
Metformin Response
16%
Patient Subgroups
16%
Trait Response
16%
Microbiome Data
16%
Metformin Therapy
16%
Genome Composition
16%
Metabolizer
16%
Personalized Medicine
16%
Clinical Characteristics
16%
Genetic Data
16%
Gut Microbiota
16%
Type 2 Diabetes Mellitus (T2DM)
16%
Genotype
16%
Microbiome
16%
Metabolic Profiling
16%
Potential Impact
16%
Metabolic Pathway
16%
Specific Patient
16%
Qatar Biobank
16%
Drug Response
16%
Microbiota
16%
Qatar University
16%
Microbial Composition
16%
Comprehensive Approach
16%
Inter-individual Variation
16%
Metabolic Response
16%
Medicine and Dentistry
Glycon
100%
Metabolomics
100%
Maturity Onset Diabetes of the Young
100%
Pharmacogenomics
100%
Microbiome
30%
Arm
20%
Metabolism
20%
Drug Response
10%
Gut Microbiota
10%
Drug Therapy
10%
Genetic Analysis
10%
Personalized Medicine
10%
Immunology and Microbiology
Pharmacogenomics
100%
Microbiome
100%
Arm
66%
Metabolism
66%
Drug Response
33%
Microflora
33%
Intestine Flora
33%